MyAverix Finance
NS · Healthcare
Accretion Nutraveda Ltd (544694)
Pharmaceuticals & Biotechnology
Accretion Nutraveda Ltd (544694) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $1.94B, P/E ratio is 38.29. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 544694
Accretion Nutraveda Ltd (544694) — FAQ
What is Accretion Nutraveda Ltd's market cap?
Accretion Nutraveda Ltd (544694) has a reported market cap of $1.94B (data as of 2026-07-10).
What is 544694's P/E ratio?
The price-to-earnings (P/E) ratio for Accretion Nutraveda Ltd (544694) is 38.29 (data as of 2026-07-10).
Does Accretion Nutraveda Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Accretion Nutraveda Ltd (544694). Check the MyAverix Finance app for the latest dividend data.
What sector is Accretion Nutraveda Ltd in?
Accretion Nutraveda Ltd (544694) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 544694 listed on?
544694 is listed on NS.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.